TORgeting oncogene addiction for cancer therapy

This publication has 13 references indexed in Scilit:

• Oncogenic PI3K deregulates transcription and translation
  Nature Reviews Cancer, 2005
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
  Nature Reviews Drug Discovery, 2005
• mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events
  Cell, 2005
• CCI‐779 in metastatic melanoma
  Cancer, 2005
• PROLINE HYDROXYLATION AND GENE EXPRESSION
  Annual Review of Biochemistry, 2005
• Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance
  Nature Cell Biology, 2005
• ABL Oncogenes and Phosphoinositide 3-Kinase: Mechanism of Activation and Downstream Effectors
  Cancer Research, 2005
• mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
  Nature Medicine, 2004
• Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
  Oncogene, 2004
• Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
  JNCI Journal of the National Cancer Institute, 1999